$3.59
-0.07-1.91%
Últ. Act.: Oct 23, 4:00 PM
TriSalus Life Sciences (TLSI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TriSalus Life Sciences (TLSI) publicó su última previsión de agosto 6, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $54M - $57M para el período.
En comparación con la previsión anterior, TriSalus Life Sciences mantenido redujo su previsión de ingresos desde un rango anterior de $54M - $57M.
TriSalus Life Sciences ha emitido 10 actualizaciones de orientación entre el marzo 11, 2024 y el agosto 6, 2026. During this period, the company raised its outlook 5 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.16 | $-0.13 | $-0.17 |
| Actual | $-0.16 | $0.03 | $-0.21 | $-0.96 |
| Surprise | -45.5% | +118.8% | -61.5% | -464.7% |
| Revenue | ||||
| Estimate | $10.3M | $10.5M | $13.0M | $11.6M |
| Actual | $11.4M | $8.9M | $13.2M | $11.6M |
| Surprise | +11.1% | -14.9% | +1.42% | -0.70% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.06 | $-0.11 | $-0.10 |
| Revenue | ||||
| Consensus | $14.0M | $19.3M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.16 | $-0.11 | -45.5 % |
| Q1 | May 12, 2026 | $0.03 | $-0.16 | 118.8 % |
| Q4 | Mar 5, 2026 | $-0.21 | $-0.13 | -61.5 % |
| Q3 | Nov 13, 2025 | $-0.96 | $-0.17 | -464.7 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $11.41M | $10.27M | 11.1 % |
| Q1 | May 12, 2026 | $8.90M | $10.45M | -14.9 % |
| Q4 | Mar 5, 2026 | $13.21M | $13.02M | 1.42 % |
| Q3 | Nov 13, 2025 | $11.57M | $11.65M | -0.70 % |